Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001636178-26-000005

CFO AND TREASURER sold 10,000 shares at an average $593.17 ($5,931,683)

  • CFO AND TREASURER acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

EDGEMOND JAMES · CFO AND TREASURER

Table I: Non-derivative

23 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-30 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 $135.42 $1,354,200 28,876 D
2026-03-30 Sale : show line 2 in the form 10b5-1 −40 $581.73 $23,269 28,836 D
2026-03-30 Sale : show line 3 in the form 10b5-1 −120 $583.52 $70,023 28,716 D
2026-03-30 Sale : show line 4 in the form 10b5-1 −120 $585.17 $70,221 28,596 D
2026-03-30 Sale : show line 5 in the form 10b5-1 −437 $586.27 $256,202 28,159 D
2026-03-30 Sale : show line 6 in the form 10b5-1 −860 $587.35 $505,125 27,299 D
2026-03-30 Sale : show line 7 in the form 10b5-1 −1,487 $588.42 $874,974 25,812 D
2026-03-30 Sale : show line 8 in the form 10b5-1 −1,196 $589.23 $704,724 24,616 D
Open-market sales · 10,000 sh · avg $593.17 · $5,931,683

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-30 Exercise or conversion : show line 24 in the form 10b5-1 Stock Option −10,000 132,500 D
Loading xslF345X06/primarydocument.xml…